Richard Pelletier's Colleagues at Morningside BioPharma Advisory
Richard Pelletier's Contact Details
N/A
Greater Boston Area
Morningside BioPharma Advisory
Richard Pelletier's Company Details
Morningside Biopharma Advisory (MBA) is a biopharmaceutical incubator that brings innovative therapies rapidly to market by building a portfolio of companies around prototype assets focused on infection, immunity, and inflammation. MBA is backed by Morningside Ventures, who have established an enviable reputation over its several decades of existence as an independently-minded, science-focused, life sciences investor. During the past several years, Morningside has advanced some of its portfolio build through the shared services of MBA under the leadership of its internal team of highly experienced biopharma executives and entrepreneurs.Our innovative and globally sourced assets have begun to advance through discovery and into clinical development, and now form the basis of 4 companies within Morningside Ventures' extensive portfolio. MBA's operating model provides the financial wherewithal, timing, expertise, and ability to grow our science into therapeutic opportunities with meaningful patient benefits, protected IP, and large commercial market opportunities.We select and advance promising therapeutics by rigorous diligence around the associated disease biology in addition to close engagement with recognized world experts, who inspire and guide us to translate their life's work into novel human treatments.